Skip to main content
Top
Published in: Digestive Diseases and Sciences 3/2017

01-03-2017 | Original Article

Hepatic Encephalopathy Is Associated with Persistent Learning Impairments Despite Adequate Medical Treatment: A Multicenter, International Study

Authors: Silvia Nardelli, Sanath Allampati, Oliviero Riggio, Kevin D. Mullen, Ravi Prakash, Stefania Gioia, Ariel Unser, Melanie B. White, Andrew C. Fagan, James B. Wade, Alessio Farcomeni, Edith A. Gavis, Jasmohan S. Bajaj

Published in: Digestive Diseases and Sciences | Issue 3/2017

Login to get access

Abstract

Background

Hepatic encephalopathy (HE) is considered reversible regarding mental status but may not be cognitively in single-center studies.

Aim

To evaluate persistence of learning impairment in prior HE compared to those who never experienced HE (no-HE) in a multicenter study.

Methods

A total of 174 outpatient cirrhotics from three centers (94 Virginia, 30 Ohio, and 50 Rome; 36 prior HE) underwent psychometric hepatic encephalopathy score (PHES) and inhibitory control (ICT) testing at baseline and then at least 7 days apart. ICT learning (change in 2nd half lures compared to 1st half) was compared between patient groups at both visits. Change in the PHES individual sub-tests and total score between visits was compared in both groups. US versus Italian trends were also analyzed.

Results

HE patients had worse PHES and ICT results compared to no-HE patients at baseline. Significant improvement (1st half 7.1 vs. 2nd half 6.2, p < 0.0001) was observed in no-HE, but not in HE (1st half 7.9 vs. 2nd half 7.8, p = 0.1) at baseline. At retesting (median 20 days later), no-HE patients continued with significant learning (1st half 6.0 vs. 2nd half 5.4, p < 0.0001), while HE patients again did not improve (1st half 7.8 vs. 2nd half 6.9, p = 0.37). Between visits, no-HE patients improved significantly on four PHES sub-tests and overall score, while HE patients only improved on two sub-tests with similar overall PHES score. Trends were similar between US and Italian subjects.

Conclusion

In this multicenter study, prior HE patients showed persistent significant learning impairment compared to those without prior HE, despite adequate medical therapy. This persistent change should increase efforts to reduce the first HE episode.
Appendix
Available only for authorised users
Literature
1.
go back to reference Bajaj JS, Wade JB, Sanyal AJ. Spectrum of neurocognitive impairment in cirrhosis: implications for the assessment of hepatic encephalopathy. Hepatology. 2009;50:2014–2021.CrossRefPubMed Bajaj JS, Wade JB, Sanyal AJ. Spectrum of neurocognitive impairment in cirrhosis: implications for the assessment of hepatic encephalopathy. Hepatology. 2009;50:2014–2021.CrossRefPubMed
2.
go back to reference Prasad S, Dhiman RK, Duseja A, et al. Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy. Hepatology. 2007;45:549–559.CrossRefPubMed Prasad S, Dhiman RK, Duseja A, et al. Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy. Hepatology. 2007;45:549–559.CrossRefPubMed
3.
go back to reference Sotil EU, Gottstein J, Ayala E, Randolph C, Blei AT. Impact of preoperative overt hepatic encephalopathy on neurocognitive function after liver transplantation. Liver Transpl. 2009;15:184–192.CrossRefPubMed Sotil EU, Gottstein J, Ayala E, Randolph C, Blei AT. Impact of preoperative overt hepatic encephalopathy on neurocognitive function after liver transplantation. Liver Transpl. 2009;15:184–192.CrossRefPubMed
4.
go back to reference Chavarria L, Cordoba J. Encephalopathy and liver transplantation. Metab Brain Dis. 2013;28:285–292.CrossRefPubMed Chavarria L, Cordoba J. Encephalopathy and liver transplantation. Metab Brain Dis. 2013;28:285–292.CrossRefPubMed
5.
go back to reference Tryc AB, Pflugrad H, Goldbecker A, et al. Newonset cognitive dysfunction impairs the quality of life in patients after liver transplantation. Liver Transpl. 2014;20:807–814.CrossRefPubMed Tryc AB, Pflugrad H, Goldbecker A, et al. Newonset cognitive dysfunction impairs the quality of life in patients after liver transplantation. Liver Transpl. 2014;20:807–814.CrossRefPubMed
6.
go back to reference Bajaj JS, Schubert CM, Heuman DM, et al. Persistence of cognitive impairment after resolution of overt hepatic encephalopathy. Gastroenterology. 2010;138:2332–2340.CrossRefPubMedPubMedCentral Bajaj JS, Schubert CM, Heuman DM, et al. Persistence of cognitive impairment after resolution of overt hepatic encephalopathy. Gastroenterology. 2010;138:2332–2340.CrossRefPubMedPubMedCentral
7.
go back to reference Riggio O, Ridola L, Pasquale C, et al. Evidence of persistent cognitive impairment after resolution of overt hepatic encephalopathy. Clin Gastroenterol Hepatol. 2011;9:181–183.CrossRefPubMed Riggio O, Ridola L, Pasquale C, et al. Evidence of persistent cognitive impairment after resolution of overt hepatic encephalopathy. Clin Gastroenterol Hepatol. 2011;9:181–183.CrossRefPubMed
9.
10.
go back to reference Sharma P, Sharma BC, Agrawal A, Sarin SK. Primary prophylaxis of overt hepatic encephalopathy in patients with cirrhosis: an open labeled randomized controlled trial of lactulose versus no lactulose. J Gastroenterol Hepatol. 2012;27:1329–1335.CrossRefPubMed Sharma P, Sharma BC, Agrawal A, Sarin SK. Primary prophylaxis of overt hepatic encephalopathy in patients with cirrhosis: an open labeled randomized controlled trial of lactulose versus no lactulose. J Gastroenterol Hepatol. 2012;27:1329–1335.CrossRefPubMed
11.
go back to reference Calamia M, Markon K, Tranel D. Scoring higher the second time around: meta-analyses of practice effects in neuropsychological assessment. Clin Neuropsychol. 2012;26:543–570.CrossRefPubMed Calamia M, Markon K, Tranel D. Scoring higher the second time around: meta-analyses of practice effects in neuropsychological assessment. Clin Neuropsychol. 2012;26:543–570.CrossRefPubMed
12.
go back to reference McCaffrey RJ, Duff K, Westervelt HJ, eds. Practitioner’s guide to evaluating change with neuropsychological assessment instruments. New York, NY: Springer; 2000. McCaffrey RJ, Duff K, Westervelt HJ, eds. Practitioner’s guide to evaluating change with neuropsychological assessment instruments. New York, NY: Springer; 2000.
13.
go back to reference Cooper DB, Epker M, Lacritz L, et al. Effects of practice on category fluency in Alzheimer’s disease. Clin Neuropsychol. 2001;15:125–128.CrossRefPubMed Cooper DB, Epker M, Lacritz L, et al. Effects of practice on category fluency in Alzheimer’s disease. Clin Neuropsychol. 2001;15:125–128.CrossRefPubMed
14.
go back to reference Helkala E-L, Kivipelto M, Hallikainen M, et al. Usefulness of repeated presentation of mini-mental state examination as a diagnostic procedure—a population-based study. Acta Neurol Scand. 2002;106:341–346.CrossRefPubMed Helkala E-L, Kivipelto M, Hallikainen M, et al. Usefulness of repeated presentation of mini-mental state examination as a diagnostic procedure—a population-based study. Acta Neurol Scand. 2002;106:341–346.CrossRefPubMed
15.
go back to reference Zehnder AE, Bläsi S, Berres M, Spiegel R, Monsch AU. Lack of practice effects on neuropsychological tests as early cognitive markers of Alzheimer disease? Am J Alzheimers Dis Other Demen. 2007;22:416–426.CrossRefPubMed Zehnder AE, Bläsi S, Berres M, Spiegel R, Monsch AU. Lack of practice effects on neuropsychological tests as early cognitive markers of Alzheimer disease? Am J Alzheimers Dis Other Demen. 2007;22:416–426.CrossRefPubMed
16.
go back to reference Vilstrup H, Amodio P, Bajaj J, et al. Hepatic encephalopathy in chronic liver disease: 2014 practice guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver. Hepatology. 2014;60:715–735.CrossRefPubMed Vilstrup H, Amodio P, Bajaj J, et al. Hepatic encephalopathy in chronic liver disease: 2014 practice guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver. Hepatology. 2014;60:715–735.CrossRefPubMed
17.
go back to reference Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT. Hepatic encephalopathy definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology. 2002;35:716–721.CrossRefPubMed Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT. Hepatic encephalopathy definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology. 2002;35:716–721.CrossRefPubMed
18.
go back to reference Bajaj JS, Hafeezullah M, Franco J, et al. Inhibitory control test for the diagnosis of minimal hepatic encephalopathy. Gastroenterology. 2008;135:1591–1600.CrossRefPubMed Bajaj JS, Hafeezullah M, Franco J, et al. Inhibitory control test for the diagnosis of minimal hepatic encephalopathy. Gastroenterology. 2008;135:1591–1600.CrossRefPubMed
19.
go back to reference Arguedas MR, DeLawrence TG, McGuire BM. Influence of hepatic encephalopathy on health-related quality of life in patients with cirrhosis. Dig Dis Sci. 2003;48:1622–1626.CrossRefPubMed Arguedas MR, DeLawrence TG, McGuire BM. Influence of hepatic encephalopathy on health-related quality of life in patients with cirrhosis. Dig Dis Sci. 2003;48:1622–1626.CrossRefPubMed
20.
go back to reference Moscucci F, Nardelli S, Pentassuglio I, et al. Previous overt hepatic encephalopathy rather than minimal hepatic encephalopathy impairs health-related quality of life in cirrhotic patients. Liver Int. 2011;31:1505–1510.CrossRefPubMed Moscucci F, Nardelli S, Pentassuglio I, et al. Previous overt hepatic encephalopathy rather than minimal hepatic encephalopathy impairs health-related quality of life in cirrhotic patients. Liver Int. 2011;31:1505–1510.CrossRefPubMed
21.
go back to reference Rovira A, Alonso J, Córdoba J. MR imaging findings in hepatic encephalopathy. Am J Neuroradiol. 2008;29:1612–1621.CrossRefPubMed Rovira A, Alonso J, Córdoba J. MR imaging findings in hepatic encephalopathy. Am J Neuroradiol. 2008;29:1612–1621.CrossRefPubMed
23.
go back to reference Bajaj JS, Ananthakrishnan AN, McGinley EL, Hoffmann RG, Brasel KJ. Deleterious effect of cirrhosis on outcomes after motor vehicle crashes using the nationwide inpatient sample. Am J Gastroenterol. 2008;103:1674–1681.CrossRefPubMed Bajaj JS, Ananthakrishnan AN, McGinley EL, Hoffmann RG, Brasel KJ. Deleterious effect of cirrhosis on outcomes after motor vehicle crashes using the nationwide inpatient sample. Am J Gastroenterol. 2008;103:1674–1681.CrossRefPubMed
24.
go back to reference Nabi E, Thacker LR, Wade JB, et al. Diagnosis of covert hepatic encephalopathy without specialized tests. Clin Gastroenterol Hepatol. 2014;12:1384–1389.CrossRefPubMed Nabi E, Thacker LR, Wade JB, et al. Diagnosis of covert hepatic encephalopathy without specialized tests. Clin Gastroenterol Hepatol. 2014;12:1384–1389.CrossRefPubMed
25.
go back to reference Gold JM, Goldberg RW, McNary SW, Dixon LB, Lehman AF. Cognitive correlates of job tenure among patients with severe mental illness. Am J Psychiatry. 2002;159:1395–1402.CrossRefPubMed Gold JM, Goldberg RW, McNary SW, Dixon LB, Lehman AF. Cognitive correlates of job tenure among patients with severe mental illness. Am J Psychiatry. 2002;159:1395–1402.CrossRefPubMed
26.
go back to reference Versavel M, van Laack D, Evertz C, Unger S, Meier F, Kuhlmann J. Test–retest reliability and influence of practice effects on performance in a multi-user computerized psychometric test system for use in clinical pharmacological studies. Arzneimittelforschung. 1997;47:781–786.PubMed Versavel M, van Laack D, Evertz C, Unger S, Meier F, Kuhlmann J. Test–retest reliability and influence of practice effects on performance in a multi-user computerized psychometric test system for use in clinical pharmacological studies. Arzneimittelforschung. 1997;47:781–786.PubMed
27.
go back to reference Lemay S, Bédard MA, Rouleau I, Tremblay PL. Practice effect and test–retest reliability of attentional and executive tests in middle-aged to elderly subjects. Clin Neuropsychol. 2004;18:284–302.CrossRefPubMed Lemay S, Bédard MA, Rouleau I, Tremblay PL. Practice effect and test–retest reliability of attentional and executive tests in middle-aged to elderly subjects. Clin Neuropsychol. 2004;18:284–302.CrossRefPubMed
28.
go back to reference Duff K, Lyketsos CG, Beglinger LJ, et al. Practice effects predict cognitive outcome in amnestic mild cognitive impairment. Am J Geriatr Psychiatry. 2011;19:932–939.CrossRefPubMedPubMedCentral Duff K, Lyketsos CG, Beglinger LJ, et al. Practice effects predict cognitive outcome in amnestic mild cognitive impairment. Am J Geriatr Psychiatry. 2011;19:932–939.CrossRefPubMedPubMedCentral
29.
go back to reference Hassenstab J, Ruvolo D, Jasielec M, Xiong C, Grant E, Morris JC. Absence of practice effects in preclinical Alzheimer’s disease. Neuropsychology. 2015;29:940–948.CrossRefPubMedPubMedCentral Hassenstab J, Ruvolo D, Jasielec M, Xiong C, Grant E, Morris JC. Absence of practice effects in preclinical Alzheimer’s disease. Neuropsychology. 2015;29:940–948.CrossRefPubMedPubMedCentral
30.
go back to reference Machulda MM, Pankratz VS, Christianson TJ, et al. Practice effects and longitudinal cognitive change in normal aging vs. incident mild cognitive impairment and dementia in the Mayo Clinic Study of Aging. Clin Neuropsychol. 2013;27:1247–1264.CrossRefPubMed Machulda MM, Pankratz VS, Christianson TJ, et al. Practice effects and longitudinal cognitive change in normal aging vs. incident mild cognitive impairment and dementia in the Mayo Clinic Study of Aging. Clin Neuropsychol. 2013;27:1247–1264.CrossRefPubMed
31.
go back to reference Lucidi C, Ginanni Corradini S, Abraldes JG, et al. Hepatic encephalopathy expands the predictivity of model for end-stage liver disease in liver transplant setting: evidence by means of 2 independent cohorts. Liver Transpl. 2016;22:1333–1342. doi:10.1002/lt.24517.CrossRefPubMed Lucidi C, Ginanni Corradini S, Abraldes JG, et al. Hepatic encephalopathy expands the predictivity of model for end-stage liver disease in liver transplant setting: evidence by means of 2 independent cohorts. Liver Transpl. 2016;22:1333–1342. doi:10.​1002/​lt.​24517.CrossRefPubMed
32.
go back to reference Görg B, Karababa A, Shafigullina A, Bidmon HJ, Häussinger D. Ammonia-induced senescence in cultured rat astrocytes and in human cerebral cortex in hepatic encephalopathy. Glia. 2015;63:37–50.CrossRefPubMed Görg B, Karababa A, Shafigullina A, Bidmon HJ, Häussinger D. Ammonia-induced senescence in cultured rat astrocytes and in human cerebral cortex in hepatic encephalopathy. Glia. 2015;63:37–50.CrossRefPubMed
33.
go back to reference Matsusue E, Kinoshita T, Ohama E, Ogawa T. Cerebral cortical and white matter lesions in chronic hepatic encephalopathy: MR-pathologic correlations. AJNR Am J Neuroradiol. 2005;26:347–351.PubMed Matsusue E, Kinoshita T, Ohama E, Ogawa T. Cerebral cortical and white matter lesions in chronic hepatic encephalopathy: MR-pathologic correlations. AJNR Am J Neuroradiol. 2005;26:347–351.PubMed
34.
go back to reference Shawcross DL, Wright G, Olde Damink SW, et al. Role of ammonia and inflammation in minimal hepatic encephalopathy. Metab Brain Dis. 2007;22:125–138.CrossRefPubMed Shawcross DL, Wright G, Olde Damink SW, et al. Role of ammonia and inflammation in minimal hepatic encephalopathy. Metab Brain Dis. 2007;22:125–138.CrossRefPubMed
35.
go back to reference Pomier-Layrargues G, Spahr L, Butterworth RF. Increased manganese concentrations in pallidum of cirrhotic patients. Lancet. 1995;345:735.CrossRefPubMed Pomier-Layrargues G, Spahr L, Butterworth RF. Increased manganese concentrations in pallidum of cirrhotic patients. Lancet. 1995;345:735.CrossRefPubMed
36.
go back to reference Zieve L, Doizaki WM, Zieve J. Synergism between mercaptans and ammonia or fatty acids in the production of coma: a possible role for mercaptans in the pathogenesis of hepatic coma. J Lab Clin Med. 1974;83:16–28.PubMed Zieve L, Doizaki WM, Zieve J. Synergism between mercaptans and ammonia or fatty acids in the production of coma: a possible role for mercaptans in the pathogenesis of hepatic coma. J Lab Clin Med. 1974;83:16–28.PubMed
Metadata
Title
Hepatic Encephalopathy Is Associated with Persistent Learning Impairments Despite Adequate Medical Treatment: A Multicenter, International Study
Authors
Silvia Nardelli
Sanath Allampati
Oliviero Riggio
Kevin D. Mullen
Ravi Prakash
Stefania Gioia
Ariel Unser
Melanie B. White
Andrew C. Fagan
James B. Wade
Alessio Farcomeni
Edith A. Gavis
Jasmohan S. Bajaj
Publication date
01-03-2017
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 3/2017
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-016-4425-6

Other articles of this Issue 3/2017

Digestive Diseases and Sciences 3/2017 Go to the issue